Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
Authors
Keywords
-
Journal
CNS SPECTRUMS
Volume 24, Issue 5, Pages 461-466
Publisher
Cambridge University Press (CUP)
Online
2019-10-01
DOI
10.1017/s1092852919001470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine
- (2019) Satoshi Deyama et al. AMERICAN JOURNAL OF PSYCHIATRY
- Explaining Naltrexone’s Interference With Ketamine’s Antidepressant Effect
- (2019) Michael Wang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Rigorous Translational Models Are Key to Studying Ketamine’s Antidepressant Mechanism: Response to Wang and Kaplin
- (2019) Boris D. Heifets et al. AMERICAN JOURNAL OF PSYCHIATRY
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice
- (2015) Linda Nguyen et al. BEHAVIOURAL BRAIN RESEARCH
- The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
- (2015) Florian Freudenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
- (2013) Mark J. Niciu et al. JOURNAL OF NEURAL TRANSMISSION
- An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan
- (2012) Edward C. Lauterbach MEDICAL HYPOTHESES
- New Therapeutic Strategy for Mood Disorders
- (2011) R. Crupi et al. CURRENT MEDICINAL CHEMISTRY
- Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
- (2011) Matthew J. Robson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication
- (2011) Shawn M. McClintock et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Glutamatergic Modulators: The Future of Treating Mood Disorders?
- (2010) Carlos Zarate et al. HARVARD REVIEW OF PSYCHIATRY
- Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
- (2009) Pierre Blier et al. AMERICAN JOURNAL OF PSYCHIATRY
- Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
- (2009) A. A. Nierenberg et al. PSYCHOLOGICAL MEDICINE
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications
- (2008) Srijan Sen et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now